Brian Elsbernd - Net Worth and Insider Trading
Brian Elsbernd Net Worth
The estimated net worth of Brian Elsbernd is at least $4 Million dollars as of 2025-04-18. Brian Elsbernd is the Chief Compliance/Legal Officer of Catalyst Pharmaceuticals Inc and owns about 188,564 shares of Catalyst Pharmaceuticals Inc (CPRX) stock worth over $4 Million. Details can be seen in Brian Elsbernd's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Brian Elsbernd has not made any transactions after 2025-03-03 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Brian Elsbernd
Brian Elsbernd Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Brian Elsbernd owns 1 companies in total, including Catalyst Pharmaceuticals Inc (CPRX) .
Click here to see the complete history of Brian Elsbernd’s form 4 insider trades.
Insider Ownership Summary of Brian Elsbernd
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2025-03-03 | Chief Compliance/Legal Officer |
Brian Elsbernd Latest Holdings Summary
Brian Elsbernd currently owns a total of 1 stock. Brian Elsbernd owns 188,564 shares of Catalyst Pharmaceuticals Inc (CPRX) as of March 3, 2025, with a value of $4 Million.
Latest Holdings of Brian Elsbernd
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CPRX | Catalyst Pharmaceuticals Inc | 2025-03-03 | 188,564 | 22.52 | 4,246,461 |
Holding Weightings of Brian Elsbernd
Brian Elsbernd Form 4 Trading Tracker
According to the SEC Form 4 filings, Brian Elsbernd has made a total of 5 transactions in Catalyst Pharmaceuticals Inc (CPRX) over the past 5 years, including 0 buys and 5 sells. The most-recent trade in Catalyst Pharmaceuticals Inc is the sale of 62,975 shares on March 3, 2025, which brought Brian Elsbernd around $1 Million.
Insider Trading History of Brian Elsbernd
- 1
Brian Elsbernd Trading Performance
Brian Elsbernd Ownership Network
Ownership Network List of Brian Elsbernd
Ownership Network Relation of Brian Elsbernd
Brian Elsbernd Owned Company Details
What does Catalyst Pharmaceuticals Inc do?
Who are the key executives at Catalyst Pharmaceuticals Inc?
Brian Elsbernd is the Chief Compliance/Legal Officer of Catalyst Pharmaceuticals Inc. Other key executives at Catalyst Pharmaceuticals Inc include Chief Medical Officer Gary Ingenito , Chief Commercial Officer Carmen Jeffrey Del , and VP Development & Management Steve Miller .
Catalyst Pharmaceuticals Inc (CPRX) Insider Trades Summary
Over the past 18 months, Brian Elsbernd made 3 insider transaction in Catalyst Pharmaceuticals Inc (CPRX) with a net sale of 101,231. Other recent insider transactions involving Catalyst Pharmaceuticals Inc (CPRX) include a net sale of 505,000 shares made by Gary Ingenito , a net sale of 800,000 shares made by Patrick J Mcenany , and a net sale of 240,000 shares made by Steve Miller .
In summary, during the past 3 months, insiders sold 318,398 shares of Catalyst Pharmaceuticals Inc (CPRX) in total and bought 0 shares, with a net sale of 318,398 shares. During the past 18 months, 1,964,409 shares of Catalyst Pharmaceuticals Inc (CPRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,964,409 shares.
Catalyst Pharmaceuticals Inc (CPRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Catalyst Pharmaceuticals Inc Insider Transactions
Brian Elsbernd Mailing Address
Above is the net worth, insider trading, and ownership report for Brian Elsbernd. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Brian Elsbernd's mailing address is: Coral Gables Fl 33134.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
